In:
Der Nervenarzt, Springer Science and Business Media LLC, Vol. 92, No. 12 ( 2021-12), p. 1276-1282
Abstract:
The ongoing COVID-19 pandemic is a global health crisis. New challenges are constantly emerging especially for the healthcare system, not least with the emergence of various viral mutations. Given the variety of immunomodulatory and immunosuppressive therapies for multiple sclerosis (MS) and the immense developments in vaccine production, there is a high need of information for people with MS. The aim of this article is therefore to provide an overview of MS and COVID-19 as well as to clarify the implications for patients with MS, especially regarding vaccination and to formulate appropriate recommendations.
Type of Medium:
Online Resource
ISSN:
0028-2804
,
1433-0407
DOI:
10.1007/s00115-021-01155-4
Language:
German
Publisher:
Springer Science and Business Media LLC
Publication Date:
2021
detail.hit.zdb_id:
1462945-8
detail.hit.zdb_id:
123291-5
SSG:
2,1